Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Regulation Of Insulin Secretion R-HSA-422356,4/77,5.96364763568482e-7,8.114693140114164e-5,0,0,77.92172211350294,1116.8063293144362,MARCKS;PRKAR2B;PRKAR2A;CACNA1C
Neuronal System R-HSA-112316,6/386,7.583825364592676e-7,8.114693140114164e-5,0,0,25.792105263157893,363.4643569110734,PRKCB;PRKAR2B;KCNA1;PRKAR2A;RPS6KA1;KCNA3
Integration Of Energy Metabolism R-HSA-163685,4/105,2.073757699394748e-6,1.47928049223492e-4,0,0,56.24045261669024,735.9709024259415,MARCKS;PRKAR2B;PRKAR2A;CACNA1C
Neurotransmitter Receptors And Postsynaptic Signal Transmission R-HSA-112314,4/182,1.837390490652668e-5,9.12519191032085e-4,0,0,31.78812199036918,346.6360910520617,PRKCB;PRKAR2B;PRKAR2A;RPS6KA1
Post NMDA Receptor Activation Events R-HSA-438064,3/61,2.132054184654404e-5,9.12519191032085e-4,0,0,68.70344827586207,738.9632657780077,PRKAR2B;PRKAR2A;RPS6KA1
Activation Of NMDA Receptors And Postsynaptic Events R-HSA-442755,3/74,3.812212524462508e-5,0.001359689133724961,0,0,56.08732394366197,570.6725771438854,PRKAR2B;PRKAR2A;RPS6KA1
CREB1 Phosphorylation Thru Activation Of Adenylate Cyclase R-HSA-442720,2/12,5.022152730310081e-5,0.001535343834694796,0,0,249.65,2471.3020247349314,PRKAR2B;PRKAR2A
Transmission Across Chemical Synapses R-HSA-112315,4/246,5.967567271068344e-5,0.0015963242450107822,0,0,23.305785123966945,226.68572593692943,PRKCB;PRKAR2B;PRKAR2A;RPS6KA1
"Cell Cycle, Mitotic R-HSA-69278",5/523,7.750573203957274e-5,0.001842914072940952,0,0,14.452034452034452,136.790799084987,CDKN1A;PRKCB;PRKAR2B;KIF2C;AURKA
PKA Activation In Glucagon Signaling R-HSA-164378,2/16,9.11177629974979e-5,0.0019499201281464548,0,0,178.28571428571428,1658.6557887027404,PRKAR2B;PRKAR2A
PKA Activation R-HSA-163615,2/17,1.0321185160705684e-4,0.0020079396585372875,0,0,166.39166666666668,1527.2636618368022,PRKAR2B;PRKAR2A
Hemostasis R-HSA-109582,5/576,1.2219419836234996e-4,0.0021340020433114637,0,0,13.0749023305941,117.80354928878276,PRKCB;PRKAR2B;PRKAR2A;PLEK;KIF2C
PKA-mediated Phosphorylation Of CREB R-HSA-111931,2/19,1.2963563814508892e-4,0.0021340020433114637,0,0,146.8014705882353,1313.9880817962558,PRKAR2B;PRKAR2A
GPCR Downstream Signaling R-HSA-388396,5/619,1.7125260013050588e-4,0.00261771831628059,0,0,12.132297669756952,105.21578523335332,PRKCB;PRKAR2B;PRKAR2A;RPS6KA1;ADRB2
ADORA2B Mediated Anti-Inflammatory Cytokine Production R-HSA-9660821,3/131,2.0852947952210103e-4,0.002768598246267281,0,0,31.021875,262.92373431613515,PRKAR2B;PRKAR2A;ADRB2
DARPP-32 Events R-HSA-180024,2/24,2.0868016842799032e-4,0.002768598246267281,0,0,113.4090909090909,961.10890422201,PRKAR2B;PRKAR2A
Cell Cycle R-HSA-1640170,5/654,2.213468808536539e-4,0.002768598246267281,0,0,11.457271542017304,96.42187085871406,CDKN1A;PRKCB;PRKAR2B;KIF2C;AURKA
Factors Involved In Megakaryocyte Development And Platelet Production R-HSA-983231,3/136,2.3287274968603297e-4,0.002768598246267281,0,0,29.84812030075188,249.680075290572,PRKAR2B;PRKAR2A;KIF2C
Signaling By GPCR R-HSA-372790,5/689,2.8199114112326275e-4,0.003176110747388328,0,0,10.851327035537562,88.69478539042689,PRKCB;PRKAR2B;PRKAR2A;RPS6KA1;ADRB2
G Alpha (S) Signaling Events R-HSA-418555,3/153,3.2922931303196065e-4,0.003522753649441979,0,0,26.442666666666668,212.03729330865093,PRKAR2B;PRKAR2A;ADRB2
Glucagon Signaling In Metabolic Regulation R-HSA-163359,2/32,3.734250375722719e-4,0.0038053789543079134,0,0,83.13333333333334,656.1542143574874,PRKAR2B;PRKAR2A
CaM Pathway R-HSA-111997,2/33,3.973053137316762e-4,0.0038216860461685247,0,0,80.4475806451613,629.9693586370835,PRKAR2B;PRKAR2A
Anti-inflammatory Response Favoring Leishmania Infection R-HSA-9662851,3/165,4.107419582330657e-4,0.0038216860461685247,0,0,24.469135802469136,190.7991968166656,PRKAR2B;PRKAR2A;ADRB2
Ca-dependent Events R-HSA-111996,2/35,4.472442885735218e-4,0.0039879282397805695,0,0,75.56439393939394,582.7832554136846,PRKAR2B;PRKAR2A
FCGR3A-mediated IL10 Synthesis R-HSA-9664323,2/38,5.275811191520497e-4,0.004315248549968663,0,0,69.25694444444444,522.6965599068795,PRKAR2B;PRKAR2A
G2/M Transition R-HSA-69275,3/182,5.469165717946331e-4,0.004315248549968663,0,0,22.126256983240225,166.19505756471946,CDKN1A;PRKAR2B;AURKA
DAG And IP3 Signaling R-HSA-1489509,2/39,5.558029199639917e-4,0.004315248549968663,0,0,67.38175675675676,505.03278857308806,PRKAR2B;PRKAR2A
Mitotic G2-G2/M Phases R-HSA-453274,3/184,5.646119598089839e-4,0.004315248549968663,0,0,21.879558011049724,163.64535048765396,CDKN1A;PRKAR2B;AURKA
Glucagon-like Peptide-1 (GLP1) Regulates Insulin Secretion R-HSA-381676,2/42,0.00064478045984749295,0.004519901455107342,0,0,62.31875,457.8309705931631,PRKAR2B;PRKAR2A
Vasopressin Regulates Renal Water Homeostasis Via Aquaporins R-HSA-432040,2/42,0.00064478045984749295,0.004519901455107342,0,0,62.31875,457.8309705931631,PRKAR2B;PRKAR2A
GPER1 Signaling R-HSA-9634597,2/43,6.758731147824064e-4,0.004519901455107342,0,0,60.795731707317074,443.7787597089313,PRKAR2B;PRKAR2A
Voltage Gated Potassium Channels R-HSA-1296072,2/43,6.758731147824064e-4,0.004519901455107342,0,0,60.795731707317074,443.7787597089313,KCNA1;KCNA3
Signal Transduction R-HSA-162582,8/2465,7.317491986962286e-4,0.004745282682454331,0,0,5.706145706145706,41.198786991765175,CDKN1A;PRKCB;PRKAR2B;PRKAR2A;RPS6KA1;STMN2;KIF2C;ADRB2
PLC Beta Mediated Events R-HSA-112043,2/47,8.073799549727844e-4,0.005081744422475761,0,0,55.38055555555555,394.40459836307184,PRKAR2B;PRKAR2A
TP53 Regulates Transcription Of Cell Cycle Genes R-HSA-6791312,2/49,8.773987974909651e-4,0.005364666933230472,0,0,53.0186170212766,373.1741306231756,CDKN1A;AURKA
Aquaporin-mediated Transport R-HSA-445717,2/50,9.13470506242016e-4,0.005430074675994207,0,0,51.911458333333336,363.2898548418271,PRKAR2B;PRKAR2A
G-protein Mediated Events R-HSA-112040,2/52,9.877327017010398e-4,0.00571283238281142,0,0,49.83,344.82850534778163,PRKAR2B;PRKAR2A
Axon Guidance R-HSA-422475,4/519,0.0010267913926663675,0.0057824567902790185,0,0,10.8,74.31821811014713,VASP;PRKAR2A;RPS6KA1;CACNA1C
Nervous System Development R-HSA-9675108,4/545,0.0012309952430328368,0.00675469184638531,0,0,10.267229997359388,68.78974585077997,VASP;PRKAR2A;RPS6KA1;CACNA1C
Leishmania Infection R-HSA-9658195,3/247,0.001323757550111788,0.007082102893098065,0,0,16.178688524590164,107.2207143761236,PRKAR2B;PRKAR2A;ADRB2
AURKA Activation By TPX2 R-HSA-8854518,2/72,0.0018837899979258688,0.009832464867222827,0,0,35.55714285714286,223.10221103497707,PRKAR2B;AURKA
Developmental Biology R-HSA-1266738,5/1073,0.002098567789821781,0.01069270254813955,0,0,6.811437626044367,42.00273129100753,VASP;CDKN1A;PRKAR2A;RPS6KA1;CACNA1C
Senescence-Associated Secretory Phenotype (SASP) R-HSA-2559582,2/81,0.0023764924719155735,0.011827195092789133,0,0,31.492088607594937,190.2792816750188,CDKN1A;RPS6KA1
Intracellular Signaling By Second Messengers R-HSA-9006925,3/306,0.002440520708293551,0.011869805263064089,0,0,12.98943894389439,78.13853965009811,CDKN1A;PRKAR2B;PRKAR2A
Regulation Of PLK1 Activity At G2/M Transition R-HSA-2565942,2/87,0.0027352221778139145,0.013007501023381728,0,0,29.26029411764706,172.6808725566614,PRKAR2B;AURKA
Opioid Signaling R-HSA-111885,2/88,0.0027973432696242373,0.013013727384773629,0,0,28.91860465116279,170.0149390044448,PRKAR2B;PRKAR2A
Hedgehog Off State R-HSA-5610787,2/98,0.003454866951884673,0.0157306708021983,0,0,25.893229166666668,146.76208059313473,PRKAR2B;PRKAR2A
Potassium Channels R-HSA-1296071,2/102,0.003736208591480751,0.016657263303685017,0,0,24.8525,138.91761980413474,KCNA1;KCNA3
M Phase R-HSA-68886,3/380,0.004491720469842855,0.01885001254109991,0,0,10.40053050397878,56.22027016341332,PRKCB;PRKAR2B;KIF2C
TFAP2 (AP-2) Family Regulates Transcription Of Cell Cycle Factors R-HSA-8866911,1/5,0.0044922927083929694,0.01885001254109991,0,0,293.79411764705884,1588.072397289777,CDKN1A
Disinhibition Of SNARE Formation R-HSA-114516,1/5,0.0044922927083929694,0.01885001254109991,0,0,293.79411764705884,1588.072397289777,PRKCB
Response To Elevated Platelet Cytosolic Ca2+ R-HSA-76005,2/130,0.00599208526644116,0.024013390065053132,0,0,19.388671875,99.21795698165909,PRKCB;PLEK
CREB Phosphorylation R-HSA-199920,1/7,0.006283877774032595,0.024013390065053132,0,0,195.84313725490196,992.8792720611536,RPS6KA1
RSK Activation R-HSA-444257,1/7,0.006283877774032595,0.024013390065053132,0,0,195.84313725490196,992.8792720611536,RPS6KA1
RUNX1 Regulates Transcription Of Genes Involved In Differentiation Of Myeloid Cells R-HSA-8939246,1/7,0.006283877774032595,0.024013390065053132,0,0,195.84313725490196,992.8792720611536,PRKCB
RUNX3 Regulates CDKN1A Transcription R-HSA-8941855,1/7,0.006283877774032595,0.024013390065053132,0,0,195.84313725490196,992.8792720611536,CDKN1A
Signaling By Hedgehog R-HSA-5358351,2/135,0.0064465840748537725,0.024202964772258025,0,0,18.655075187969924,94.10002147267744,PRKAR2B;PRKAR2A
ROBO Receptors Bind AKAP5 R-HSA-9010642,1/8,0.007178528720410204,0.026486295623582477,0,0,167.85714285714286,828.6537822644398,PRKAR2A
Adrenoceptors R-HSA-390696,1/9,0.008072419310050151,0.029279622582215805,0,0,146.86764705882354,707.7995527019895,ADRB2
Acetylcholine Regulates Insulin Secretion R-HSA-399997,1/10,0.008965550093347357,0.03145291344223499,0,0,130.54248366013073,615.425022203049,MARCKS
STAT5 Activation Downstream Of FLT3 ITD Mutants R-HSA-9702518,1/10,0.008965550093347357,0.03145291344223499,0,0,130.54248366013073,615.425022203049,CDKN1A
Cellular Senescence R-HSA-2559583,2/165,0.009490728285320497,0.03275832021062236,0,0,15.19861963190184,70.78665790754837,CDKN1A;RPS6KA1
Mitotic Prometaphase R-HSA-68877,2/186,0.011934843347695625,0.04054057899058513,0,0,13.449728260869565,59.55933945612225,PRKAR2B;KIF2C
AKT Phosphorylates Targets In Cytosol R-HSA-198323,1/14,0.01253048655713669,0.04125421728041925,0,0,90.3574660633484,395.7287161899813,CDKN1A
TP53 Regulates Transcription Of Genes Involved In G1 Cell Cycle Arrest R-HSA-6804116,1/14,0.01253048655713669,0.04125421728041925,0,0,90.3574660633484,395.7287161899813,CDKN1A
Phase 2 - Plateau Phase R-HSA-5576893,1/15,0.01341982690512007,0.041620912430372393,0,0,83.89915966386555,361.6911269349327,CACNA1C
WNT5A-dependent Internalization Of FZD4 R-HSA-5099900,1/15,0.01341982690512007,0.041620912430372393,0,0,83.89915966386555,361.6911269349327,PRKCB
Depolymerisation Of Nuclear Lamina R-HSA-4419969,1/15,0.01341982690512007,0.041620912430372393,0,0,83.89915966386555,361.6911269349327,PRKCB
Signaling By FLT3 ITD And TKD Mutants R-HSA-9703648,1/15,0.01341982690512007,0.041620912430372393,0,0,83.89915966386555,361.6911269349327,CDKN1A
Cell-extracellular Matrix Interactions R-HSA-446353,1/16,0.014308410919694987,0.04278941035413136,0,0,78.30196078431372,332.5412031884909,VASP
Signaling By ROBO Receptors R-HSA-376176,2/209,0.014895145669006873,0.04278941035413136,0,0,11.941425120772946,50.23423084681995,VASP;PRKAR2A
FOXO-mediated Transcription Of Cell Cycle Genes R-HSA-9617828,1/17,0.015196239191186836,0.04278941035413136,0,0,73.40441176470588,307.3227868353231,CDKN1A
Aberrant Regulation Of Mitotic G1/S Transition In Cancer Due To RB1 Defects R-HSA-9659787,1/17,0.015196239191186836,0.04278941035413136,0,0,73.40441176470588,307.3227868353231,CDKN1A
Formation Of Senescence-Associated Heterochromatin Foci (SAHF) R-HSA-2559584,1/17,0.015196239191186836,0.04278941035413136,0,0,73.40441176470588,307.3227868353231,CDKN1A
Gastrin-CREB Signaling Pathway Via PKC And MAPK R-HSA-881907,1/17,0.015196239191186836,0.04278941035413136,0,0,73.40441176470588,307.3227868353231,RPS6KA1
Trafficking Of GluR2-containing AMPA Receptors R-HSA-416993,1/17,0.015196239191186836,0.04278941035413136,0,0,73.40441176470588,307.3227868353231,PRKCB
TP53 Regulates Transcription Of Genes Involved In G2 Cell Cycle Arrest R-HSA-6804114,1/18,0.0160833123117468,0.04356745360397234,0,0,69.08304498269896,285.3111137768628,AURKA
VEGFR2 Mediated Cell Proliferation R-HSA-5218921,1/18,0.0160833123117468,0.04356745360397234,0,0,69.08304498269896,285.3111137768628,PRKCB
Signaling By FLT3 Fusion Proteins R-HSA-9703465,1/18,0.0160833123117468,0.04356745360397234,0,0,69.08304498269896,285.3111137768628,CDKN1A
Branched-chain Amino Acid Catabolism R-HSA-70895,1/21,0.01874000670829494,0.049950434785381345,0,0,58.71176470588235,233.50224496360525,BCKDK
Signaling By Rho GTPases R-HSA-194315,3/644,0.0189064729795135,0.049950434785381345,0,0,6.034633385335414,23.94693954273854,PRKCB;STMN2;KIF2C
ERK/MAPK Targets R-HSA-198753,1/22,0.019624065171284413,0.05121402373969347,0,0,55.91316526610644,219.7945772360195,RPS6KA1
"Signaling By Rho GTPases, Miro GTPases And RHOBTB3 R-HSA-9716542",3/660,0.020170894048244584,0.05200688344969086,0,0,5.882800608828006,22.963598079297807,PRKCB;STMN2;KIF2C
Miscellaneous Transport And Binding Events R-HSA-5223345,1/23,0.02050737145707836,0.05224497014065201,0,0,53.36898395721925,207.44368622737056,ADD2
RHO GTPases Activate NADPH Oxidases R-HSA-5668599,1/24,0.02138992615773652,0.05349985439591611,0,0,51.0460358056266,196.26359569838613,PRKCB
"Platelet Activation, Signaling And Aggregation R-HSA-76002",2/254,0.02149994148620928,0.05349985439591611,0,0,9.78670634920635,37.57806594286372,PRKCB;PLEK
Constitutive Signaling By AKT1 E17K In Cancer R-HSA-5674400,1/26,0.023152783214921657,0.05643327594991588,0,0,46.95764705882353,176.82560723797164,CDKN1A
RHO GTPase Effectors R-HSA-195258,2/269,0.023928905817327203,0.05643327594991588,0,0,9.229868913857675,34.45203728422377,PRKCB;KIF2C
FLT3 Signaling In Disease R-HSA-9682385,1/27,0.02403308675659661,0.05643327594991588,0,0,45.14932126696833,168.33128827465845,CDKN1A
CREB1 Phosphorylation Thru NMDA Receptor-Mediated Activation Of RAS Signaling R-HSA-442742,1/27,0.02403308675659661,0.05643327594991588,0,0,45.14932126696833,168.33128827465845,RPS6KA1
Transport Of Small Molecules R-HSA-382551,3/706,0.02406578995619244,0.05643327594991588,0,0,5.484779516358464,20.44157553570812,PRKAR2B;PRKAR2A;ADD2
Cell Cycle Checkpoints R-HSA-69620,2/271,0.024261034520524583,0.05643327594991588,0,0,9.160315985130111,34.06615010917153,CDKN1A;KIF2C
"Adrenaline,noradrenaline Inhibits Insulin Secretion R-HSA-400042",1/28,0.0249126411012733,0.056637495969687424,0,0,43.474945533769066,160.52601632867996,CACNA1C
Recycling Pathway Of L1 R-HSA-437239,1/28,0.0249126411012733,0.056637495969687424,0,0,43.474945533769066,160.52601632867996,RPS6KA1
Immune System R-HSA-168256,5/1943,0.025142813631403298,0.056637495969687424,0,0,3.5810113519091846,13.189520719904891,VASP;CDKN1A;PRKCB;RPS6KA1;KIF2C
Adaptive Immune System R-HSA-1280218,3/733,0.0265321177584982,0.05883787612919835,0,0,5.2745205479452055,19.143341126376782,VASP;PRKCB;KIF2C
MAPK Targets/ Nuclear Events Mediated By MAP Kinases R-HSA-450282,1/30,0.02666950460061794,0.05883787612919835,0,0,40.47261663286004,146.68225415832842,RPS6KA1
"Glutamate Binding, Activation Of AMPA Receptors And Synaptic Plasticity R-HSA-399721",1/31,0.02754681494066949,0.06015324895207418,0,0,39.12156862745098,140.51952455455398,PRKCB
Phase 0 - Rapid Depolarisation R-HSA-5576892,1/32,0.028423378470110255,0.06082602992603595,0,0,37.85768500948767,134.79392621731594,CACNA1C
Generation Of Second Messenger Molecules R-HSA-202433,1/32,0.028423378470110255,0.06082602992603595,0,0,37.85768500948767,134.79392621731594,VASP
Metabolism R-HSA-1430728,5/2049,0.030880241694036983,0.06542942299528628,0,0,3.375357519193136,11.738274026138235,BCKDK;MARCKS;PRKAR2B;PRKAR2A;CACNA1C
G Alpha (I) Signaling Events R-HSA-418594,2/312,0.031483154722672484,0.06568601681585547,0,0,7.932258064516129,27.432149060411696,PRKAR2B;PRKAR2A
Aberrant Regulation Of Mitotic Cell Cycle Due To RB1 Defects R-HSA-9687139,1/36,0.03192217639649051,0.06568601681585547,0,0,33.52436974789916,115.4731604004656,CDKN1A
Transcriptional Regulation By AP-2 (TFAP2) Family Of Transcription Factors R-HSA-8864260,1/36,0.03192217639649051,0.06568601681585547,0,0,33.52436974789916,115.4731604004656,CDKN1A
NCAM1 Interactions R-HSA-419037,1/37,0.0327950148043916,0.06683936350609335,0,0,32.591503267973856,111.38077026649428,CACNA1C
Diseases Of Mitotic Cell Cycle R-HSA-9675126,1/38,0.03366710996592093,0.0679694484217649,0,0,31.70906200317965,107.5328454820737,CDKN1A
Amine Ligand-Binding Receptors R-HSA-375280,1/40,0.03540907294557409,0.07081814589114818,0,0,30.07993966817496,100.49067723322013,ADRB2
RND1 GTPase Cycle R-HSA-9696273,1/42,0.03714807008538698,0.07293290824103499,0,0,28.609756097560975,94.20744821276294,STMN2
Kinesins R-HSA-983189,1/42,0.03714807008538698,0.07293290824103499,0,0,28.609756097560975,94.20744821276294,KIF2C
Transcriptional Regulation By TP53 R-HSA-3700989,2/354,0.03965632130974999,0.07663709237165771,0,0,6.970880681818182,22.49855166852595,CDKN1A;AURKA
SUMOylation Of DNA Replication Proteins R-HSA-4615885,1/45,0.03975101520212152,0.07663709237165771,0,0,26.655080213903744,85.9658295948253,AURKA
G Alpha (Z) Signaling Events R-HSA-418597,1/47,0.0414826184608072,0.07856000310276763,0,0,25.493606138107417,81.1329113370927,PRKCB
Cyclin D Associated Events In G1 R-HSA-69231,1/47,0.0414826184608072,0.07856000310276763,0,0,25.493606138107417,81.1329113370927,CDKN1A
Nuclear Envelope Breakdown R-HSA-2980766,1/53,0.04665975146146969,0.08758935800661855,0,0,22.54524886877828,69.09833217880467,PRKCB
FBXL7 Down-Regulates AURKA During Mitotic Entry And In Early Mitosis R-HSA-8854050,1/54,0.04752003528742647,0.08842858740442838,0,0,22.11875693673696,67.38709029166962,AURKA
NCAM Signaling For Neurite Out-Growth R-HSA-375165,1/57,0.05009648993282979,0.09241938660022046,0,0,20.930672268907564,62.66233736405012,CACNA1C
Role Of GTSE1 In G2/M Progression After G2 Checkpoint R-HSA-8852276,1/59,0.05181046820697307,0.09317176635539696,0,0,20.20689655172414,59.815708753826954,CDKN1A
Transcriptional Regulation Of Granulopoiesis R-HSA-9616222,1/59,0.05181046820697307,0.09317176635539696,0,0,20.20689655172414,59.815708753826954,CDKN1A
SCF(Skp2)-mediated Degradation Of P27/P21 R-HSA-187577,1/59,0.05181046820697307,0.09317176635539696,0,0,20.20689655172414,59.815708753826954,CDKN1A
Infectious Disease R-HSA-5663205,3/961,0.05265106188120466,0.09388202003878177,0,0,3.97160751565762,11.692686058337827,PRKAR2B;PRKAR2A;ADRB2
DNA Damage/Telomere Stress Induced Senescence R-HSA-2559586,1/61,0.05352152544266997,0.09388202003878177,0,0,19.531372549019608,57.18144005818292,CDKN1A
Nuclear Events (Kinase And Transcription Factor Activation) R-HSA-198725,1/61,0.05352152544266997,0.09388202003878177,0,0,19.531372549019608,57.18144005818292,RPS6KA1
MAP Kinase Activation R-HSA-450294,1/62,0.05437596012922433,0.09460532900531712,0,0,19.210221793635487,55.93696029523851,RPS6KA1
FOXO-mediated Transcription R-HSA-9614085,1/65,0.0569348954637786,0.09747254103398896,0,0,18.30698529411765,52.46501611587855,CDKN1A
p53-Dependent G1 DNA Damage Response R-HSA-69563,1/65,0.0569348954637786,0.09747254103398896,0,0,18.30698529411765,52.46501611587855,CDKN1A
Activation Of NF-kappaB In B Cells R-HSA-1169091,1/66,0.05778641961430449,0.09814518886873937,0,0,18.02443438914027,51.387689221977354,PRKCB
G1/S DNA Damage Checkpoints R-HSA-69615,1/67,0.058637217599069806,0.0988060202063066,0,0,17.750445632798574,50.34710965358108,CDKN1A
Interleukin-17 Signaling R-HSA-448424,1/69,0.06033663736484967,0.1000933364037041,0,0,17.226643598615915,48.3692416453001,RPS6KA1
Loss Of Nlp From Mitotic Centrosomes R-HSA-380259,1/69,0.06033663736484967,0.1000933364037041,0,0,17.226643598615915,48.3692416453001,PRKAR2B
Signaling By Interleukins R-HSA-449147,2/453,0.06167818188255797,0.10153177632974927,0,0,5.413248337028825,15.080362693436184,CDKN1A;RPS6KA1
APC/C:Cdh1 Mediated Degradation Of Cdc20 And APC/C:Cdh1 Targets In Late Mitosis/Early G1 R-HSA-174178,1/73,0.06372678840915502,0.1041033032027418,0,0,16.266339869281047,44.783677915691136,AURKA
Disease R-HSA-1643685,4/1736,0.06477160339087604,0.10500850852763235,0,0,3.0105575717584956,8.239558864199305,CDKN1A;PRKAR2B;PRKAR2A;ADRB2
COPI-dependent Golgi-to-ER Retrograde Traffic R-HSA-6811434,1/78,0.06794823417091082,0.1093302414479317,0,0,15.206264323911382,40.88978353793229,KIF2C
Downstream Signaling Events Of B Cell Receptor (BCR) R-HSA-1168372,1/79,0.0687903633714564,0.10985923702605724,0,0,15.0105580693816,40.178634862671224,PRKCB
Recruitment Of NuMA To Mitotic Centrosomes R-HSA-380320,1/80,0.06963177394208621,0.11037925647115888,0,0,14.819806403574088,39.48788238772356,PRKAR2B
Centrosome Maturation R-HSA-380287,1/81,0.07047246645026504,0.11089049867909352,0,0,14.633823529411766,38.81670264132201,PRKAR2B
Cyclin E Associated Events During G1/S Transition R-HSA-69202,1/82,0.0713124414727928,0.1113931567531216,0,0,14.452432824981845,38.16431494463284,CDKN1A
Signaling By Receptor Tyrosine Kinases R-HSA-9006934,2/496,0.07230596600860724,0.11212664294088368,0,0,4.931174089068826,12.953447928830162,PRKCB;RPS6KA1
Cyclin A:Cdk2-associated Events At S Phase Entry R-HSA-69656,1/84,0.0729902413804037,0.11237346514680858,0,0,14.10276399716513,36.91299089130259,CDKN1A
Cell Junction Organization R-HSA-446728,1/86,0.07466517827093744,0.11413105821414722,0,0,13.76955017301038,35.728422579909434,VASP
APC/C-mediated Degradation Of Cell Cycle Proteins R-HSA-174143,1/87,0.07550157451990408,0.1145910421791452,0,0,13.60875512995896,35.15960381916263,AURKA
PCP/CE Pathway R-HSA-4086400,1/88,0.07633725672986817,0.11504347140980133,0,0,13.451656524678835,34.60565311468726,PRKCB
Regulation Of TP53 Activity Thru Phosphorylation R-HSA-6804756,1/90,0.07800648136170299,0.11673697210772337,0,0,13.148050231328488,33.540194413490916,AURKA
Unattached Kinetochores Signal Amplification Via A MAD2 Inhibitory Signal R-HSA-141444,1/93,0.08050497738089572,0.11881424247939092,0,0,12.717391304347826,32.040656856642045,KIF2C
VEGFA-VEGFR2 Pathway R-HSA-4420097,1/93,0.08050497738089572,0.11881424247939092,0,0,12.717391304347826,32.040656856642045,PRKCB
Transcriptional Regulation By RUNX3 R-HSA-8878159,1/95,0.08216708746364133,0.1203949059017859,0,0,12.445556946182728,31.101452445343085,CDKN1A
MyD88 Cascade Initiated On Plasma Membrane R-HSA-975871,1/96,0.08299707803951369,0.1203949059017859,0,0,12.313931888544891,30.64875924889407,RPS6KA1
Anchoring Of Basal Body To Plasma Membrane R-HSA-5620912,1/97,0.08382635971666402,0.1203949059017859,0,0,12.185049019607844,30.20683114705019,PRKAR2B
EML4 And NUDC In Mitotic Spindle Formation R-HSA-9648025,1/97,0.08382635971666402,0.1203949059017859,0,0,12.185049019607844,30.20683114705019,KIF2C
L1CAM Interactions R-HSA-373760,1/99,0.08548279870958994,0.12089071766423576,0,0,11.935174069627852,29.353845802361935,RPS6KA1
TRAF6 Mediated Induction Of NFkB And MAP Kinases Upon TLR7/8 Or 9 Activation R-HSA-975138,1/101,0.0871364089944587,0.12089071766423576,0,0,11.69529411764706,28.539797811620943,RPS6KA1
MyD88 Dependent Cascade Initiated On Endosome R-HSA-975155,1/102,0.08796215478207874,0.12089071766423576,0,0,11.578916715200933,28.146593675405043,RPS6KA1
Signaling By VEGF R-HSA-194138,1/102,0.08796215478207874,0.12089071766423576,0,0,11.578916715200933,28.146593675405043,PRKCB
Generic Transcription Pathway R-HSA-212436,3/1190,0.08797156020152776,0.12089071766423576,0,0,3.1668070766638583,7.69769000527639,CDKN1A;PRKCB;AURKA
Toll Like Receptor 3 (TLR3) Cascade R-HSA-168164,1/103,0.08878719509547235,0.12089071766423576,0,0,11.46482122260669,27.76221178459644,RPS6KA1
Toll Like Receptor 7/8 (TLR7/8) Cascade R-HSA-168181,1/103,0.08878719509547235,0.12089071766423576,0,0,11.46482122260669,27.76221178459644,RPS6KA1
Cargo Recognition For Clathrin-Mediated Endocytosis R-HSA-8856825,1/104,0.08961153050884178,0.12089071766423576,0,0,11.352941176470589,27.38637392725137,ADRB2
MHC Class II Antigen Presentation R-HSA-2132295,1/104,0.08961153050884178,0.12089071766423576,0,0,11.352941176470589,27.38637392725137,KIF2C
PI3K/AKT Signaling In Cancer R-HSA-2219528,1/105,0.0904351615790966,0.12089071766423576,0,0,11.243212669683258,27.0188131977752,CDKN1A
Toll Like Receptor 9 (TLR9) Cascade R-HSA-168138,1/106,0.0912580888842393,0.12089071766423576,0,0,11.135574229691876,26.659273431080635,RPS6KA1
Resolution Of Sister Chromatid Cohesion R-HSA-2500257,1/106,0.0912580888842393,0.12089071766423576,0,0,11.135574229691876,26.659273431080635,KIF2C
Interleukin-4 And Interleukin-13 Signaling R-HSA-6785807,1/107,0.092080312987245,0.12089071766423576,0,0,11.029966703662597,26.307508679008535,CDKN1A
MyD88-independent TLR4 Cascade R-HSA-166166,1/107,0.092080312987245,0.12089071766423576,0,0,11.029966703662597,26.307508679008535,RPS6KA1
Signaling By B Cell Receptor (BCR) R-HSA-983705,1/109,0.09372265379690269,0.12229663361303154,0,0,10.824618736383442,25.6263685491649,PRKCB
Mitotic Spindle Checkpoint R-HSA-69618,1/110,0.0945427716606664,0.1225161529220004,0,0,10.724770642201834,25.296548009342803,KIF2C
Golgi-to-ER Retrograde Transport R-HSA-8856688,1/112,0.09618090509764518,0.1225161529220004,0,0,10.530471648118708,24.65735665214607,KIF2C
Mitotic Prophase R-HSA-68875,1/112,0.09618090509764518,0.1225161529220004,0,0,10.530471648118708,24.65735665214607,PRKCB
MyD88:MAL(TIRAP) Cascade Initiated On Plasma Membrane R-HSA-166058,1/112,0.09618090509764518,0.1225161529220004,0,0,10.530471648118708,24.65735665214607,RPS6KA1
Signaling By NTRK1 (TRKA) R-HSA-187037,1/114,0.09781623925032576,0.1238619834294066,0,0,10.343050494534095,24.04412406695568,RPS6KA1
TCR Signaling R-HSA-202403,1/116,0.09944877860449489,0.12508516361749092,0,0,10.162148337595909,23.455382166428738,VASP
Membrane Trafficking R-HSA-199991,2/599,0.0999512288719203,0.12508516361749092,0,0,4.058835845896147,9.347794936578303,KIF2C;ADRB2
Transcriptional Regulation By RUNX2 R-HSA-8878166,1/119,0.10189235727874028,0.12604025698063823,0,0,9.902293120638086,22.615236719842347,CDKN1A
RHO GTPases Activate Formins R-HSA-5663220,1/119,0.10189235727874028,0.12604025698063823,0,0,9.902293120638086,22.615236719842347,KIF2C
Cell-Cell Communication R-HSA-1500931,1/120,0.10270549097155077,0.12631594866616014,0,0,9.818586258032624,22.3460193071682,VASP
Platelet Degranulation R-HSA-114608,1/125,0.10676074066511164,0.13055313429905083,0,0,9.420303605313093,21.074773673487663,PLEK
Cardiac Conduction R-HSA-5576891,1/126,0.10756971077056704,0.130794989232394,0,0,9.344470588235296,20.83458271705315,CACNA1C
G1/S Transition R-HSA-69206,1/129,0.10999247141798286,0.1324105679242878,0,0,9.124080882352942,20.13997932609556,CDKN1A
RNA Polymerase II Transcription R-HSA-73857,3/1312,0.1101358929463702,0.1324105679242878,0,0,2.8530175706646297,6.293871695369529,CDKN1A;PRKCB;AURKA
Vesicle-mediated Transport R-HSA-5653656,2/637,0.110824993528383,0.13249468500041317,0,0,3.8084645669291337,8.377871614992861,KIF2C;ADRB2
Signaling By NTRKs R-HSA-166520,1/132,0.11240901927776754,0.13364183403023475,0,0,8.913785361472833,19.48206824738867,RPS6KA1
Toll Like Receptor 4 (TLR4) Cascade R-HSA-166016,1/140,0.11882288723970202,0.1404867285596477,0,0,8.39737621667372,17.887429414854076,RPS6KA1
Beta-catenin Independent WNT Signaling R-HSA-3858494,1/142,0.12041950100185368,0.14081843286555565,0,0,8.277430120984564,17.521447135021635,PRKCB
Clathrin-mediated Endocytosis R-HSA-8856828,1/142,0.12041950100185368,0.14081843286555565,0,0,8.277430120984564,17.521447135021635,ADRB2
Mitotic G1 Phase And G1/S Transition R-HSA-453279,1/147,0.12439909049755812,0.1446815509047687,0,0,7.991941982272361,16.65728827120197,CDKN1A
Cytokine Signaling In Immune System R-HSA-1280215,2/702,0.13013205931934432,0.15053113888832262,0,0,3.443214285714286,7.021421520214079,CDKN1A;RPS6KA1
Regulation Of TP53 Activity R-HSA-5633007,1/157,0.13230731019735142,0.15222453968942584,0,0,7.475867269984917,15.120898125775808,AURKA
S Phase R-HSA-69242,1/161,0.1354516701926492,0.15425672211018063,0,0,7.2875,14.568735518025488,CDKN1A
Cellular Responses To Stress R-HSA-2262752,2/722,0.13623317271927302,0.15425672211018063,0,0,3.344097222222222,6.666081120158694,CDKN1A;RPS6KA1
Toll-like Receptor Cascades R-HSA-168898,1/162,0.1362360770038511,0.15425672211018063,0,0,7.241870661308002,14.435699026304276,RPS6KA1
Gene Expression (Transcription) R-HSA-74160,3/1449,0.1374522353929625,0.15481462302154722,0,0,2.563762102351314,5.087731543399803,CDKN1A;PRKCB;AURKA
Cellular Responses To Stimuli R-HSA-8953897,2/736,0.14054477350205208,0.15707646914814322,0,0,3.2779291553133514,6.4320482003774435,CDKN1A;RPS6KA1
SUMO E3 Ligases SUMOylate Target Proteins R-HSA-3108232,1/168,0.1409284209179603,0.15707646914814322,0,0,6.979570271222261,13.676490075658847,AURKA
Separation Of Sister Chromatids R-HSA-2467813,1/170,0.1424871782645395,0.15799096450057745,0,0,6.896275670031327,13.43741562775988,KIF2C
SUMOylation R-HSA-2990846,1/174,0.14559668293998512,0.16060665025338566,0,0,6.735464127847671,12.97866635801621,AURKA
Intra-Golgi And Retrograde Golgi-to-ER Traffic R-HSA-6811442,1/181,0.1510127069380722,0.1657267655628075,0,0,6.47124183006536,12.233179215630082,KIF2C
Cilium Assembly R-HSA-5617833,1/186,0.15486142607713563,0.16908339377809706,0,0,6.294753577106518,11.741129142703194,PRKAR2B
Muscle Contraction R-HSA-397014,1/196,0.16250948405474008,0.1765331451153014,0,0,5.968929110105581,10.845657098350197,CACNA1C
Ub-specific Processing Proteases R-HSA-5689880,1/201,0.16630895555805134,0.17974806307789387,0,0,5.818235294117647,10.437379086756568,ADRB2
Transcriptional Regulation By RUNX1 R-HSA-8878171,1/204,0.16858081808691658,0.18128791492763893,0,0,5.731382208055636,10.203809066850312,PRKCB
G Alpha (Q) Signaling Events R-HSA-416476,1/212,0.17461056685495951,0.1868333065348067,0,0,5.511848341232228,9.619261834720568,RPS6KA1
Mitotic Anaphase R-HSA-68882,1/232,0.1895047592338975,0.20154431518745508,0,0,5.029539088362617,8.36583928133549,KIF2C
Mitotic Metaphase And Anaphase R-HSA-2555396,1/233,0.1902427648031118,0.20154431518745508,0,0,5.007606490872211,8.309894188622586,KIF2C
PIP3 Activates AKT Signaling R-HSA-1257604,1/268,0.21567674513609847,0.22736366236022204,0,0,4.343467724168319,6.6627689152345,CDKN1A
Organelle Biogenesis And Maintenance R-HSA-1852241,1/275,0.22067215860230568,0.2314894212788893,0,0,4.2310004293688275,6.393367960864164,PRKAR2B
Deubiquitination R-HSA-5688426,1/279,0.2235131736489448,0.23332594712621557,0,0,4.169276343630978,6.2467638903387455,ADRB2
Signaling By WNT R-HSA-195721,1/294,0.2340801049551469,0.2431705944679681,0,0,3.9528207187311786,5.739858921485836,PRKCB
Class A/1 (Rhodopsin-like Receptors) R-HSA-373076,1/327,0.25685124806145476,0.265537039058702,0,0,3.546734031035727,4.820927183584267,ADRB2
Metabolism Of Amino Acids And Derivatives R-HSA-71291,1/364,0.2816217539243379,0.289745458364463,0,0,3.1792254091719334,4.028683938699718,BCKDK
Diseases Of Signal Transduction By Growth Factor Receptors And Second Messengers R-HSA-5663202,1/424,0.32013979129858144,0.3277986379803657,0,0,2.7199276873870115,3.097990919808182,CDKN1A
RHO GTPase Cycle R-HSA-9012999,1/441,0.3306933992355967,0.3369923211257985,0,0,2.6125668449197863,2.8909714232396104,STMN2
GPCR Ligand Binding R-HSA-500792,1/458,0.3410921487770502,0.34594180018146325,0,0,2.5131934611919164,2.7031974392225986,ADRB2
Post-translational Protein Modification R-HSA-597592,2/1383,0.3565651091126767,0.3599289308967586,0,0,1.6836531498913831,1.7362478167253357,ADRB2;AURKA
Metabolism Of Proteins R-HSA-392499,2/1890,0.517961681666131,0.520393426650479,0,0,1.1979608050847457,0.7880833231331688,ADRB2;AURKA
Innate Immune System R-HSA-168249,1/1035,0.615911958755642,0.615911958755642,0,0,1.0779383320059164,0.5224241597721958,RPS6KA1
